A randomised, non-inferiority study of chloroprocaine 2% and ropivacaine 0.75% in ultrasound-guided axillary block

by Irene Sulyok, Claudio Camponovo, Oliver Zotti, Werner Haslik, Markus Köstenberger, Rudolf Likar, Chiara Leuratti, Elisabetta Donati, Oliver Kimberger
Published 2021-05-01